| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5618207 | Journal of Vascular Surgery | 2016 | 11 Pages |
Abstract
Based on this model, screening for AAA in individuals with IA is cost-effective at an ICER of $1150/QALY, well below accepted societal thresholds estimated at $60,000/QALY. Cost-effectiveness of cross-screening in these populations is sensitive to aneurysm coprevalence and risk of rupture. Further prospective study is warranted to validate this finding.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Benjamin Z. MD, Boxiang MD, Prachi MBBS, George J. PhD, Gilbert R. MD, James F. MD, Bradford B. MD, MSc, Andrew M. MD, MSc,